Immunology and Biotherapies
17.3K views | +10 today
Follow
Immunology and Biotherapies
Page Ressources et Actualités du DIU immunologie et biothérapies
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
Scoop.it!

PDL241, a novel humanized monoclonal antibody, reveals CD319 ...

PDL241, a novel humanized monoclonal antibody, reveals CD319 ... | Immunology and Biotherapies | Scoop.it
PDL241, a novel humanized IgG1 monoclonal antibody (mAb) to CD319, was generated and examined for its ability to inhibit immunoglobulin production from plasmablasts and plasma cells generated from peripheral blood ...
Gilbert C FAURE's insight:

in rheumatoid arthritis

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

A case report on efficacy of AboundTM for anti-EGFR antibody ...

Panitumumab is a full human epidermal growth factor receptor (EGFR) monoclonal antibody, an agent for metastatic colorectal cancer therapy. One of the most general adverse events of anti-EGFR monoclonal antibody ...
Gilbert C FAURE's insight:

treating a dermatological side effect of anti-EGFR antibody

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Theradiag SA (ALTHE.PA) Key Developments | Reuters.com

Connect to the most current information on stocks and bonds on Reuters.com.
Gilbert C FAURE's insight:

tocilizumab and anti-CD20

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Novel “Vaccine” Delivery Method Shuts the Door on HIV - Genetic Engineering News (blog)

Novel “Vaccine” Delivery Method Shuts the Door on HIV - Genetic Engineering News (blog) | Immunology and Biotherapies | Scoop.it
Genetic Engineering News (blog) Novel “Vaccine” Delivery Method Shuts the Door on HIV Genetic Engineering News (blog) Scientists at Caltech have demonstrated that a technique they had developed to protect mice from a lab strain of HIV delivered...
more...
No comment yet.
Rescooped by Gilbert C FAURE from Top Selling Monoclonal Antibodies 2014
Scoop.it!

Development trends for human monoclonal antibody therapeutics

Development trends for human monoclonal antibody therapeutics


Via Krishan Maggon
Gilbert C FAURE's insight:

article de 2010, mais intéressant à lire ou relire

more...
Krishan Maggon 's comment, February 11, 2014 4:44 AM
Gilbert Faure et l'ASSIM, merci beacoup
Scooped by Gilbert C FAURE
Scoop.it!

Asymmetrical Fc Engineering Greatly Enhances Antibody ...

Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies*. Zhi Liu‡,§1,; Kannan Gunasekaran‡,¶,; Wei Wang‡,¶,; Vladimir ...
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

A new classification system for chronic lung allograft dysfunction

The Journal of Heart and Lung Transplantation, Volume 33, Issue 2, Pages 127-133, February 2014, Authors:Geert M. Verleden, MD, PhD; Ganesh Raghu, PhD; Keith C. Meyer, PhD; Allan R.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Actelion gains approval in Australia for Opsumit in PAH - The Pharma Letter

Actelion gains approval in Australia for Opsumit in PAH - The Pharma Letter | Immunology and Biotherapies | Scoop.it
The Pharma Letter Actelion gains approval in Australia for Opsumit in PAH The Pharma Letter Trevor Williams, clinical director of the Department of Allergy, Immunology and Respiratory Medicine at Alfred Hospital and Monash University, Melbourne,...
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Lorvotuzumab mertansine, a CD56-targeting antibody-drug... [MAbs. 2014] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Innate Pharma acquires full rights to ANTI-NKG2A checkpoint inhibitor from Novo Nordisk A/S | Innate Pharma

Innate Pharma acquires full rights to ANTI-NKG2A checkpoint inhibitor from Novo Nordisk A/S | Innate Pharma | Immunology and Biotherapies | Scoop.it
Healthcare:
Novo Nordisk Sells Antibody Rights to Innate Pharma-http://t.co/Nt1hjucP4f
more...
No comment yet.
Rescooped by Gilbert C FAURE from Cancer Immunotherapy Review
Scoop.it!

CAR T-Cell Therapies: Positive Early Results - Clinical Oncology News

CAR T-Cell Therapies: Positive Early Results - Clinical Oncology News | Immunology and Biotherapies | Scoop.it
CAR T-Cell Therapies: Positive Early Results
Clinical Oncology News
Subsequent use of tocilizumab (Actemra, Hoffman-La Roche), an interleukin-6 inhibitor, reduced these adverse events without exerting any apparent effect on outcomes.

Via Krishan Maggon
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

New directions in immunosuppression after he... [Nat Rev Cardiol. 2013] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Gilbert C FAURE's insight:

heart transplantation

from multi to monotherapy

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Targeting co-stimulatory pathways: transplantation and autoimmunity : Nature Reviews Nephrology : Nature Publishing Group

Targeting co-stimulatory pathways: transplantation and autoimmunity : Nature Reviews Nephrology : Nature Publishing Group | Immunology and Biotherapies | Scoop.it
fascinating review of costimulatory pathway drugs in inflammation & autoimmunity... did bench work on many of these! http://t.co/sPaZK8nR9d
Gilbert C FAURE's insight:

an overview for nephrologists sustaining teaching immunological synapse to students

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Frost & Sullivan: Strong Pipeline of Monoclonal Antibodies (mAbs ...

Frost & Sullivan: Strong Pipeline of Monoclonal Antibodies (mAbs) Biosimilars in the US and Europe Lends Impetus to Global Market. The market is expected to soar from $1.2 billion of 2013 to $24 billion in 2019 ...
Gilbert C FAURE's insight:

no comment

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

EpiVax Eurotrip Spring 2014 | EpiVax, Inc. – Informatics and ...

EpiVax Eurotrip Spring 2014 | EpiVax, Inc. – Informatics and ... | Immunology and Biotherapies | Scoop.it
... EpiVax Publication (Open Access) · EpiVax on Twitter · EpiVax RSS. © 2010 EpiVax, Inc. – Informatics and Immunology, All rights reserved. • 146 Clifford St., Providence, RI 02903 • ph: 401.272.2123 • fax: 401.272.7562.
Gilbert C FAURE's insight:

Epivacs comes to old world

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Complement-Binding Anti-HLA Antibodies and Kidney Transplantation

Complement-Binding Anti-HLA Antibodies and Kidney Transplantation | Immunology and Biotherapies | Scoop.it
In their retrospective analysis of 1016 patients who had a negative CDL assay before transplantation, antibody-mediated rejection developed in 7.4% during the first year. The authors predict that antibody-mediated rejection ...
Gilbert C FAURE's insight:

letters related to a paper published in september on C1q binding anti-HLA antibodies detected by a One lambda method in a large cohort of patients from Necker and St Louis Paris Hospitals

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Frontiers | Regulatory T Cells as Immunotherapy | Frontiers in Immunotherapies and Vaccines

Regulatory T cells (Tregs) suppress exuberant immune system activation and promote immunologic tolerance.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Antibody therapy for acute myeloid leukaemia - Gasiorowski - 2013 - British Journal of Haematology - Wiley Online Library

Antibody therapy for acute myeloid leukaemia - Gasiorowski - 2013 - British Journal of Haematology - Wiley Online Library | Immunology and Biotherapies | Scoop.it
Antibody therapy in AML: http://t.co/uuOppJJbvb latest updates... #teamhaem
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Immunosuppressive T-cell antibody induction for heart transplant recipients - The Cochrane Library - Penninga - Wiley Online Library

RT @TripCVD: From Cochrane: Immunosuppressive T-cell antibody induction for heart transplant recipients http://t.co/x4W4BfHpWC
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

A New Frontier: Biologics ELN - Scientific Computing (blog)

A New Frontier: Biologics ELN - Scientific Computing (blog) | Immunology and Biotherapies | Scoop.it
Scientific Computing (blog) A New Frontier: Biologics ELN Scientific Computing (blog) In contrast — for a series of assay and study results on a single molecular entity — just the process of creating a monoclonal antibody generates a...
Gilbert C FAURE's insight:

link to a paper in scientific computing on biologics 

more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Frontiers | Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors | Frontiers in Microbial Immunology

Transitioning to human trials from preclinical models resulted in the emergence of inhibitory AAV vector immune responses which has become a hurdle for sustained correction.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis - Guma - 2013 - Pediatric Blood & Cancer - Wiley Online Library

Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis - Guma - 2013 - Pediatric Blood & Cancer - Wiley Online Library | Immunology and Biotherapies | Scoop.it
Natural killer cell therapy and aerosol interleukin2 for the treatment of osteosarcoma lung metastasis --> http://t.co/IgWYvKootm
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Science Translational Medicine | From AAAS

Preventing thrombosis without increasing bleeding risk: new antibody blocks Factor XIIa. http://t.co/COiK8Jns9W #surgery
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Down-Regulating Humoral Immune Responses: Implications for O... : Transplantation

Down-Regulating Humoral Immune Responses: Implications for O... : Transplantation | Immunology and Biotherapies | Scoop.it
Alloantibody can be a major barrier to successful organ transplantation; however, therapy to control antibody production or to alter its impact on the allograft remains limited.
more...
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

TiGenix: reaches major cell therapy milestone with 1000th implant of ChondroCelect

TiGenix: reaches major cell therapy milestone with 1000th implant of ChondroCelect | Immunology and Biotherapies | Scoop.it
From BioPortfolio: REGULATED INFORMATIONFEBRUARY 4, 2014 TiGenix reaches major cell therapy milestone with 1000th implant of ChondroCelect Leuven (BELGIUM) - February 4, 2014 - Ti...
more...
No comment yet.